Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 32

1.

Aspirin-intolerant asthma: a comprehensive review of biomarkers and pathophysiology.

Velazquez JR, Teran LM.

Clin Rev Allergy Immunol. 2013 Aug;45(1):75-86. doi: 10.1007/s12016-012-8340-0. Review.

PMID:
23184151
2.

Aspirin intolerance and nasal polyposis.

Picado C.

Curr Allergy Asthma Rep. 2002 Nov;2(6):488-93. Review.

PMID:
12428645
3.

Aspirin-induced asthma: advances in pathogenesis, diagnosis, and management.

Szczeklik A, Stevenson DD.

J Allergy Clin Immunol. 2003 May;111(5):913-21; quiz 922. Review.

PMID:
12743549
4.

Update on recent advances in the management of aspirin exacerbated respiratory disease.

Palikhe NS, Kim JH, Park HS.

Yonsei Med J. 2009 Dec 31;50(6):744-50. doi: 10.3349/ymj.2009.50.6.744. Review.

5.

Aspirin-induced asthma: clinical aspects, pathogenesis and management.

Hamad AM, Sutcliffe AM, Knox AJ.

Drugs. 2004;64(21):2417-32. Review.

PMID:
15482000
6.

Aspirin-intolerant asthma (AIA) assessment using the urinary biomarkers, leukotriene E4 (LTE4) and prostaglandin D2 (PGD2) metabolites.

Higashi N, Taniguchi M, Mita H, Yamaguchi H, Ono E, Akiyama K.

Allergol Int. 2012 Sep;61(3):393-403. doi: 10.2332/allergolint.11-RA-0403. Review.

7.

A new insight into aspirin-induced asthma.

Jawien J.

Eur J Clin Invest. 2002 Feb;32(2):134-8. Review.

PMID:
11895461
8.

Mechanisms of aspirin sensitivity.

Picado C.

Curr Allergy Asthma Rep. 2006 May;6(3):198-202. Review.

PMID:
16579869
9.

Aspirin intolerance and the cyclooxygenase-leukotriene pathways.

Szczeklik A, Sanak M, Nizankowska-Mogilnicka E, Kiełbasa B.

Curr Opin Pulm Med. 2004 Jan;10(1):51-6. Review.

PMID:
14749606
10.

[Special features of NSAID intolerance in children].

Porto Arceo JA.

Allergol Immunopathol (Madr). 2003 May-Jun;31(3):109-25. Review. Spanish.

PMID:
12783761
11.

[Aspirin-Intolerance-Syndrom : a common and interdisciplinary disease].

Umbreit C, Virchow JC, Thorn C, Hörmann K, Klimek L, Pfaar O.

Internist (Berl). 2010 Sep;51(9):1196-8, 1200-1. doi: 10.1007/s00108-010-2661-y. Review. German.

PMID:
20725708
12.

Mechanism of chronic urticaria exacerbation by aspirin.

Mastalerz L, Setkowicz M, Szczeklik A.

Curr Allergy Asthma Rep. 2005 Jul;5(4):277-83. Review.

PMID:
15967068
13.

Analgesics.

Szczeklik A.

Chem Immunol Allergy. 2010;95:170-9. doi: 10.1159/000315950. Review.

PMID:
20519889
14.

Platelets in patients with aspirin-exacerbated respiratory disease.

Laidlaw TM, Boyce JA.

J Allergy Clin Immunol. 2015 Jun;135(6):1407-14; quiz 1415. doi: 10.1016/j.jaci.2015.02.005. Review.

15.

[Aspirin-exacerbated respiratory disease].

Randerath WJ.

Dtsch Med Wochenschr. 2013 Mar;138(11):541-7. doi: 10.1055/s-0032-1332934. Review. German.

PMID:
23463477
16.

Inflammation, allergy and asthma, complex immune origin diseases: mechanisms and therapeutic agents.

Naik SR, Wala SM.

Recent Pat Inflamm Allergy Drug Discov. 2013 Jan 1;7(1):62-95. Review.

PMID:
23140569
17.

Gene-expression signatures of nasal polyps associated with chronic rhinosinusitis and aspirin-sensitive asthma.

Platt M, Metson R, Stankovic K.

Curr Opin Allergy Clin Immunol. 2009 Feb;9(1):23-8. doi: 10.1097/ACI.0b013e32831d8170. Review.

PMID:
19532090
18.

Biochemical pathogenesis of aspirin exacerbated respiratory disease (AERD).

Narayanankutty A, Reséndiz-Hernández JM, Falfán-Valencia R, Teran LM.

Clin Biochem. 2013 May;46(7-8):566-78. doi: 10.1016/j.clinbiochem.2012.12.005. Review.

PMID:
23246457
19.

Safety of COX-2 inhibitors in asthma patients with aspirin hypersensitivity.

West PM, Fernández C.

Ann Pharmacother. 2003 Oct;37(10):1497-501. Review.

PMID:
14519044
20.

Aspirin-induced rhinitis and asthma.

Szczeklik A, Nizankowska E, Sanak M, Swierczynska M.

Curr Opin Allergy Clin Immunol. 2001 Feb;1(1):27-33. Review.

PMID:
11964666
Items per page

Supplemental Content

Support Center